UEF7:XETRA:XETRA-UBS Barclays US Liquid Corporates 1-5Yr UCITS (EUR)

ETF | Others |

Last Closing

USD 12.5595

Change

0.00 (0.00)%

Market Cap

USD 0.25B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The sub-fund aims to track, before expenses, the price and income performance of the Bloomberg Barclays US Liquid Corporates" 1-5 Year Index (Total Return) (this sub-fund's Index). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing UEF7:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.57% 13% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.57% 13% F 23% F
Trailing 12 Months  
Capital Gain -0.83% 11% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.83% 11% F 21% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.38% N/A N/A 31% F
Dividend Return 0.38% N/A N/A 29% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 3.93% N/A N/A 93% A
Risk Adjusted Return 9.78% N/A N/A 31% F
Market Capitalization 0.25B 50% F 45% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike